دورية أكاديمية

Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus–Specific CD8 T-Cell Responses and High Anti–Hepatitis B Surface Antigen Titers.

التفاصيل البيبلوغرافية
العنوان: Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus–Specific CD8 T-Cell Responses and High Anti–Hepatitis B Surface Antigen Titers.
المؤلفون: Schmidt, Sarah, Mengistu, Meron, Daffis, Stephane, Ahmadi-Erber, Sarah, Deutschmann, Daniela, Grigoriev, Tetiana, Chu, Ruth, Leung, Cleo, Tomkinson, Adrian, Uddin, Mohammad Nizam, Moshkani, Safiehkhatoon, Robek, Michael D, Perry, Jason, Lauterbach, Henning, Orlinger, Klaus, Fletcher, Simon P, Balsitis, Scott
المصدر: Journal of Infectious Diseases; 4/15/2024, Vol. 229 Issue 4, p1077-1087, 11p
مصطلحات موضوعية: CELL surface antigens, HEPATITIS B, CD8 antigen, LYMPHOCYTIC choriomeningitis virus, TITERS
مستخلص: Hepatitis B Virus (HBV) is a major driver of infectious disease mortality. Curative therapies are needed and ideally should induce CD8 T cell-mediated clearance of infected hepatocytes plus anti-hepatitis B surface antigen (HBsAg) antibodies (anti-HBs) to neutralize residual virus. We developed a novel therapeutic vaccine using non-replicating arenavirus vectors. Antigens were screened for genotype conservation and magnitude and genotype reactivity of T cell response, then cloned into Pichinde virus (PICV) vectors (recombinant PICV, GS-2829) and lymphocytic choriomeningitis virus (LCMV) vectors (replication-incompetent, GS-6779). Alternating immunizations with GS-2829 and GS-6779 induced high-magnitude HBV T cell responses, and high anti-HBs titers. Dose schedule optimization in macaques achieved strong polyfunctional CD8 T cell responses against core, HBsAg, and polymerase and high titer anti-HBs. In AAV-HBV mice, GS-2829 and GS-6779 were efficacious in animals with low pre-treatment serum HBsAg. Based on these results, GS-2829 and GS-6779 could become a central component of cure regimens. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00221899
DOI:10.1093/infdis/jiad340